{
  "source": "The Daily Alpha",
  "source_name": "The Daily Alpha",
  "meta_source_name": "The Daily Alpha",
  "source_guid": "src-market-blog",
  "trust_level": 4,
  "source_type": "NEWS_WIRE",
  "group_guid": "group-simulation",
  "event_type": "SUPPLY_CHAIN",
  "published_at": "2025-12-31T20:59:19.503961",
  "upload_as_group": "group-simulation",
  "title": "Update regarding GeneSys",
  "story_body": "\"Vitality Pharma's Supply Chain Snafu Sends GeneSys Stock into a Tailspin\"\n\nTraders, buckle up! Vitality Pharma, a key supplier to GeneSys, has just dropped a bombshell that's got the Street reeling. A critical delay in their production line has left GeneSys high and dry, and its stock is paying the price. GENE shares are getting crushed, down 10% in early trading, as investors scramble to reassess the company's prospects.\n\nThe news is a major blow to GeneSys, which has been riding high on its partnership with Vitality Pharma in the healthcare space. The two companies have been working together to bring a series of innovative treatments to market, but it looks like those plans are now in jeopardy. With Vitality Pharma's supply chain in disarray, GeneSys is facing a serious shortage of critical components - and its stock price is feeling the pain.\n\nThis is a nightmare scenario for GeneSys bagholders, who were hoping the company's stock would continue to soar to the moon on the back of its partnership with Vitality Pharma. Instead, they're waking up to a harsh reality: that their investment is now at risk of serious losses. The delay is a major setback for GeneSys, and it's unclear how long it will take for the company to recover.\n\nMeanwhile, Vitality Pharma is facing its own set of problems. The company's stock is also under pressure, as investors worry about the long-term implications of this supply chain failure. Can VIT get its production line back on track, or is this just the beginning of a bigger problem? One thing's for sure: GeneSys investors are feeling the pain, and it's going to be a long day on the trading floor.",
  "validation_metadata": {
    "scenario": "Indirect Supplier Delay",
    "base_ticker": "GENE",
    "expected_tier": "GOLD",
    "expected_event": "SUPPLY_CHAIN",
    "expected_relevant_clients": [
      "550e8400-e29b-41d4-a716-446655440007",
      "550e8400-e29b-41d4-a716-446655440001"
    ],
    "relationship_hops": 1,
    "expected_feed_rank_range": "1-50",
    "validation_rules": {
      "min_score": 0,
      "max_score": 100,
      "expected_tier": "GOLD",
      "must_match_event": false,
      "expected_event": "SUPPLY_CHAIN",
      "expected_entities": [],
      "expected_relevant_clients": [],
      "relationship_hops": 1,
      "expected_feed_rank_range": "1-50"
    }
  }
}